GRIFOLS | GRF - Current Assets



GRIFOLS reported EUR5.25B in Current Assets for its fiscal quarter ending in June of 2025.


Current Assets Change Date
Alcon AG USD 6.31B 239M Jun/2025
Almirall EUR 714.05M 50.55M Jun/2025
Amadeus IT EUR 2.8B 236.9M Jun/2025
Amarin USD 573.06M 22.34M Mar/2025
argenx SE 5.83B 946.64M Jun/2025
AstraZeneca USD 28.94B 2.8B Jun/2025
Bayer EUR 33.75B 1.08B Jun/2025
Cie Automotive EUR 1.93B 86.4M Dec/2024
Demant DKK 10.2B 282M Jun/2025
Ence Energia y Celulosa EUR 503.4M 11M Jun/2025
Essilor EUR 11.03B 991M Jun/2025
Ferrovial EUR 5.64B 2.03B Jun/2025
Fresenius EUR 10.88B 1.03B Jun/2025
Fresenius Medical Care EUR 8.14B 178.09M Jun/2025
Galapagos EUR 3.26B 217.04M Jun/2025
Genmab DKK 3.91B 127M Jun/2025
GlaxoSmithKline GBP 17.67B 412M Jun/2025
GRIFOLS EUR 5.25B 393.8M Jun/2025
Hikma Pharmaceutical USD 2.26B 22M Dec/2024
Inditex EUR 16.25B 102M Apr/2025
Merck EUR 12.2B 216M Jun/2025
Novartis USD 25.94B 831M Jun/2025
Philips EUR 9.06B 394M Jun/2025
Roche Holding CHF 40.04B 6.41B Dec/2024
Sanofi 37.02B 7B Jun/2025
Smith & Nephew USD 4.63B 206M Jun/2025
UCB EUR 4.79B 1.47B Dec/2024
Viscofan EUR 810.49M 292K Jun/2025